Scientific Publication

Facing a silent crisis in its vast underwater prairies, Indonesia is pioneering a new collaborative framework to unify fragmented data and save its vital seagrass.

A landmark publication in The Lancet unveils AC01, a novel oral drug that safely improves heart function, offering a beacon of hope for millions with heart failure.

New data shows kindergarten scores strongly predict future success, but it's not a life sentence. The real test is for our education system to act.

Researchers have developed a nanoparticle that mimics diseased cells, allowing for rapid screening of cancer targets. It's a key step toward truly personal vaccines.

A groundbreaking study in Nature Water reveals wastewater analysis can detect fentanyl trends 15 months ahead of traditional data, offering a powerful new tool.

Zevra Therapeutics' new data for MIPLYFFA in infants with NPC is more than a medical update; it's a key commercial milestone to widen its market.

A breakthrough at National Tsing Hua University yields the world's brightest single-photon source, overcoming key barriers to practical quantum communication.

bioAffinity Technologies' new gene-silencing therapy kills common skin cancer cells in lab studies while leaving healthy cells untouched, hinting at a future without scars.

A single drug receptor could treat cancer, psoriasis, and liver disease. Can-Fite’s new scientific validation boosts its platform, but clinical and financial hurdles loom.

A California farm is using a data verification platform to prove its milk's nutritional superiority. It's a glimpse into the future of food transparency.

SandboxAQ's new AI model, 20,000x faster than simulation, is the first to model magnetism in catalysts, unlocking sustainable innovation for global industries.

EeroQ's breakthrough with electrons on helium opens a new front in the quantum race, promising a scalable path to millions of qubits via standard chip tech.

A new study reveals the biggest planning mistake in enterprise IT is rigid strategy. For companies betting on digital transformation, adaptability is now survival.

Maryland's SANS Academy pivots to AI and industrial security, tackling a critical skills gap that now links directly to 27% of all cyber breaches.

New research from Baycrest unmasks paratonia, an involuntary condition often mistaken as defiance, signaling a seismic shift in dementia care and treatment.

A landmark drug approval in China offers new hope for IgAN patients. But the real story is how science, strategy, and policy are converging to build a better future.

A new AI can detect Parkinson's progression where the current gold standard fails. In a stunning validation, the study was led by the very scientists who created the old method.